| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0014900 | Intron-Exon-Intron | chr10:31673662-31750166 | chr10:31384733-31461237 | 2814 nt | 0.3372 |
| hsa_ZEB1_0015400 | Exon-Exon | chr10:31676053-31676727 | chr10:31387124-31387798 | 222 nt | 0.4189 |
| hsa_ZEB1_0015500 | Exon-Exon | chr10:31676053-31678589 | chr10:31387124-31389660 | 278 nt | 0.4173 |
| hsa_ZEB1_0015600 | Exon-Exon | chr10:31676053-31678624 | chr10:31387124-31389695 | 228 nt | 0.4211 |
| hsa_ZEB1_0015200 | Intron-Exon-Intron | chr10:31676053-31681906 | chr10:31387124-31392977 | 250 nt | 0.4160 |
| hsa_ZEB1_0015800 | Intron-Exon-Intron | chr10:31676053-31772121 | chr10:31387124-31483192 | 143 nt | 0.4476 |
| hsa_ZEB1_0015900 | Exon-Exon | chr10:31676053-31784767 | chr10:31387124-31495838 | 407 nt | 0.4521 |
| hsa_ZEB1_0016000 | Exon-Exon | chr10:31676053-31791437 | chr10:31387124-31502509 | 321 nt | 0.4330 |
| hsa_ZEB1_0016100 | Exon-Exon | chr10:31676053-31799803 | chr10:31387124-31510875 | 203 nt | 0.3793 |
| hsa_ZEB1_0016200 | Exon-Exon | chr10:31676053-31803636 | chr10:31387124-31514708 | 344 nt | 0.4360 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].